4
Changes in Ownership
Vistagen Therapeutics, Inc. Filed Acc 0001415889-24-019020
CHIEF EXECUTIVE OFFICER acquired 4,854 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Singh Shawn CHIEF EXECUTIVE OFFICER | 2024-06-28 | Grant or award | +4,854 | $2.96 | $14,358 | 10,487 | D |
Loading xslF345X05/form4-07022024_100738.xml…